Literature DB >> 28919192

Magnetic resonance index of activity (MaRIA) and Clermont score are highly and equally effective MRI indices in detecting mucosal healing in Crohn's disease.

Anthony Buisson1, Bruno Pereira2, Marion Goutte3, Maud Reymond4, Christophe Allimant4, Hélène Obritin-Guilhen3, Gilles Bommelaer3, Constance Hordonneau5.   

Abstract

BACKGROUND: Magnetic resonance index of activity (MaRIA) and Clermont score are currently the two main MRI indices that have been validated compared to endoscopy in Crohn's disease (CD). AIMS: To compare the accuracy of MaRIA and Clermont score in assessing CD mucosal healing.
METHODS: Fourty-four CD patients underwent prospectively and consecutively MRI and colonoscopy.
RESULTS: Considering 207 segments, MaRIA>7 and Clermont score>8.4 demonstrated substantial accuracy to detect endoscopic ulcerations (73.9% and 74.0%, respectively) and presented with high specificity (82.1% and 81.3%) and high negative predictive value (NPV) (82.1% and 82.4%) for MaRIA and Clermont score, respectively. The sensitivity for detecting deep ulcerations was 90.9% for both MaRIA>11 and Clermont score>12.5, with a specificity of 82.0% and 80.0%, respectively. Among 44 patients, deep MRI remission predicted mucosal healing with specificity=85.3% and NPV=85.3% according to Barcelona criteria (no segmental MaRIA>7), and specificity=88.2% and NPV=85.7% according to Clermont criteria (no segmental Clermont score>8.4). In addition, MRI remission predicted mucosal healing with specificity=76.5% and NPV=86.7% according to Barcelona criteria (no segmental MaRIA>11), and specificity=79.4% and NPV=84.4% according to Clermont criteria (no segmental Clermont score>12.5).
CONCLUSION: MaRIA and Clermont score are equally effective in detecting CD endoscopic ulcerations supporting their use as therapeutic endpoints.
Copyright © 2017 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clermont score; Crohn’s disease; MRI remission; Mucosal healing

Mesh:

Substances:

Year:  2017        PMID: 28919192     DOI: 10.1016/j.dld.2017.08.033

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  13 in total

1.  Bowel wall healing assessed using magnetic resonance imaging predicts sustained clinical remission and decreased risk of surgery in Crohn's disease.

Authors:  Anthony Buisson; Constance Hordonneau; Felix Goutorbe; Christophe Allimant; Marion Goutte; Maud Reymond; Bruno Pereira; Gilles Bommelaer
Journal:  J Gastroenterol       Date:  2018-08-30       Impact factor: 7.527

2.  Assessing the inflammatory severity of the terminal ileum in Crohn disease using radiomics based on MRI.

Authors:  Honglei Ding; Jiaying Li; Kefeng Zhou; Zhichao Sun; Kefang Jiang; Chen Gao; Liangji Lu; Huani Zhang; Haibo Chen; Xuning Gao
Journal:  BMC Med Imaging       Date:  2022-07-04       Impact factor: 2.795

Review 3.  Inflammatory Bowel Disease Treatments and Predictive Biomarkers of Therapeutic Response.

Authors:  Duaa Ahmed Elhag; Manoj Kumar; Marwa Saadaoui; Anthony K Akobeng; Fatma Al-Mudahka; Mamoun Elawad; Souhaila Al Khodor
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

4.  Assessment of Ileocolonic Inflammation in Crohn's Disease: Which Surrogate Marker Is Better-MaRIA, Clermont, or PET/MR Index? Initial Results of a Feasibility Trial.

Authors:  Yan Li; Jost Langhorst; Anna Katharina Koch; Aydin Demircioglu; Felix Nensa; Julian Kirchner; Karsten Beiderwellen; Onofrio Catalano; Michael Forsting; Ken Herrmann; Lale Umutlu
Journal:  J Nucl Med       Date:  2018-11-02       Impact factor: 10.057

5.  Magnetic resonance enterography features of small bowel Crohn's disease activity: an inter-rater reliability study of small bowel active inflammation in clinical practice setting.

Authors:  Richard Tsai; Aaron Mintz; Michael Lin; Joyce Mhlanga; Adeeti Chiplunker; Amber Salter; Matthew Ciorba; Parakkal Deepak; Kathryn Fowler
Journal:  Br J Radiol       Date:  2019-05-29       Impact factor: 3.039

6.  Faecal calprotectin and magnetic resonance imaging in detecting Crohn's disease endoscopic postoperative recurrence.

Authors:  Pierre Baillet; Guillaume Cadiot; Marion Goutte; Felix Goutorbe; Hedia Brixi; Christine Hoeffel; Christophe Allimant; Maud Reymond; Hélène Obritin-Guilhen; Benoit Magnin; Gilles Bommelaer; Bruno Pereira; Constance Hordonneau; Anthony Buisson
Journal:  World J Gastroenterol       Date:  2018-02-07       Impact factor: 5.742

Review 7.  A review of magnetic resonance enterography-based indices for quantification of Crohn's disease inflammation.

Authors:  Noa Rozendorn; Marianne Michal Amitai; Rami Abraham Eliakim; Uri Kopylov; Eyal Klang
Journal:  Therap Adv Gastroenterol       Date:  2018-04-13       Impact factor: 4.409

8.  Evaluating inflammatory activity in Crohn's disease by cross-sectional imaging techniques.

Authors:  Bruno Cunha Fialho Cantarelli; Rafael Santiago de Oliveira; Aldo Maurici Araújo Alves; Bruno Jucá Ribeiro; Fernanda Velloni; Giuseppe D'Ippolito
Journal:  Radiol Bras       Date:  2020 Jan-Feb

Review 9.  Small bowel imaging in Crohn's disease patients.

Authors:  James Gauci; Lara Sammut; Martina Sciberras; Naomi Piscopo; Kristian Micallef; Kelvin Cortis; Pierre Ellul
Journal:  Ann Gastroenterol       Date:  2018-05-04

10.  Diffusion-weighted imaging and apparent diffusion coefficient values for evaluating terminal ileitis in patients with Crohn's disease.

Authors:  Evandra Durayski; Guilherme Watte; Gabriel Sartori Pacini; Diego Hermindo Roman; Marta Brenner Machado; Edson Marchiori; Bruno Hochhegger; Matteo Baldisserotto
Journal:  Radiol Bras       Date:  2019 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.